Synmosa Biopharma Net Asset Quality Index
Synmosa Biopharma net asset quality index. Synmosa Biopharma (4114) has a Net Asset Quality Index of 72.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$13.99 Billion minus total liabilities of NT$3.89 Billion yields net assets of NT$10.10 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Synmosa Biopharma (4114) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Synmosa Biopharma (2015–2025)
Net asset quality index of Synmosa Biopharma from 2015 to 2025. This chart shows how Synmosa Biopharma's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the index stands at 72.2%, representing net assets of NT$10.10 Billion against total assets of NT$13.99 Billion TWD. Check asset allocation strategy of Synmosa Biopharma to assess the company's strategic physical and investment asset allocation.
Synmosa Biopharma Net Asset Quality Index by Year (2015–2025)
Synmosa Biopharma net asset quality index by year from 2015 to 2025. The table below presents the year-by-year Net Asset Quality Index for Synmosa Biopharma from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Synmosa Biopharma market capitalisation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 72.2% | NT$10.10 Billion | NT$13.99 Billion | NT$3.89 Billion | ▲ +4.0 pp |
| 2024 | 68.3% | NT$8.40 Billion | NT$12.30 Billion | NT$3.91 Billion | ▼ -0.8 pp |
| 2023 | 69.1% | NT$8.10 Billion | NT$11.73 Billion | NT$3.63 Billion | ▲ +9.7 pp |
| 2022 | 59.4% | NT$6.65 Billion | NT$11.20 Billion | NT$4.55 Billion | ▲ +0.3 pp |
| 2021 | 59.1% | NT$6.10 Billion | NT$10.32 Billion | NT$4.22 Billion | ▲ +1.7 pp |
| 2020 | 57.4% | NT$5.95 Billion | NT$10.38 Billion | NT$4.42 Billion | ▲ +2.2 pp |
| 2019 | 55.1% | NT$4.81 Billion | NT$8.73 Billion | NT$3.92 Billion | ▼ -4.3 pp |
| 2018 | 59.4% | NT$4.49 Billion | NT$7.54 Billion | NT$3.06 Billion | ▲ +6.6 pp |
| 2017 | 52.8% | NT$3.97 Billion | NT$7.50 Billion | NT$3.54 Billion | ▼ -11.3 pp |
| 2016 | 64.1% | NT$4.35 Billion | NT$6.79 Billion | NT$2.44 Billion | ▼ -1.5 pp |
| 2015 | 65.6% | NT$3.01 Billion | NT$4.59 Billion | NT$1.58 Billion | — |